AR firm Strolll, targeting neurological disorders, raises £10.4m

Quick Summary:

In the same year it entered the US market in a $3m collaboration with US healthcare provider, Cleveland Clinic.

The funding will also be used to extend its product leadership and expand the regulatory level, which will allow the Staffordshire-based firm to target more neuro-related disorders.

IW Capital’s investment director, Isobel Egemole, added: “IW Capital are thrilled to announce our investment into Strolll.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Patrick Killeen

Category: InvestingBusiness

Markets: United Kingdom

Topics: MedTech Investment

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-03-12 @ 07:30:41 (14 hours ago)

News Timezone: GMT +8:00

News Source URL: businesscloud.co.uk

Language: English

Article Length: 370 words

Reading Time: 3 minutes read

Sentences: 13 lines

Sentence Length: 29 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © BusinessCloud

News ID: 26914175

View Article Analysis

About BusinessCloud

Main Topics: InvestingBusiness

Official Website: businesscloud.co.uk

Update Frequency: 3 posts per day

Year Established: 2016

Headquarters: United Kingdom

News Last Updated: 10 hours ago

Coverage Areas: United Kingdom

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #61

Publisher Details

Frequently Asked Questions